Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -3368.72% is 68% above its 5-year average of -10427.28%, near the high end of its 5-year range (-1842916.67%–84.34%).
71.83% above its 12-month average of -11959.42%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -895.33%.
NET PROFIT MARGIN
-3368.72%
NET PROFIT MARGIN AVG TTM
-11959.42%
NET PROFIT MARGIN AVG 3Y
-10580.90%
NET PROFIT MARGIN AVG 5Y
-10427.28%
NET PROFIT MARGIN AVG 10Y
-12818.32%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+71.83%
CURRENT VS 3Y AVG
+68.16%
CURRENT VS 5Y AVG
+67.69%
CURRENT VS 10Y AVG
+73.72%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.68%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
-38910.14%
vs the sector median at left
CRISPR Therapeutics AG
Market Cap
$5.35B
Net Profit Margin
-3368.72%
TTM Avg
-11959.42%
3Y Avg
-10580.90%
5Y Avg
-10427.28%
Market Cap
$5.22B
Net Profit Margin
25.48%
TTM Avg
34.77%
3Y Avg
31.87%
5Y Avg
32.80%
Market Cap
$5.10B
Net Profit Margin
9.22%
TTM Avg
8.68%
3Y Avg
7.83%
5Y Avg
5.80%
Market Cap
$5.61B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-101.30%
5Y Avg
-277.86%
Market Cap
$6.47B
Net Profit Margin
-5.51%
TTM Avg
7.00%
3Y Avg
-0.29%
5Y Avg
-8.82%
Market Cap
$6.63B
Net Profit Margin
10.60%
TTM Avg
11.45%
3Y Avg
11.66%
5Y Avg
12.42%
Market Cap
$2.76B
Net Profit Margin
22.69%
TTM Avg
19.73%
3Y Avg
-2.42%
5Y Avg
-44.65%
Market Cap
$8.02B
Net Profit Margin
3.60%
TTM Avg
-1.75%
3Y Avg
-5.71%
5Y Avg
-20.27%
Market Cap
$2.52B
Net Profit Margin
-54.75%
TTM Avg
-325.19%
3Y Avg
-290.00%
5Y Avg
-135445.82%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CRISPR Therapeutics AG (CRSP) | $5.35B | -3368.72% | -11959.42% | -10580.90% | -10427.28% |
| Doximity, Inc. (DOCS)vs › | $5.22B | 25.48% | 34.77% | 31.87% | 32.80% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 9.22% | 8.68% | 7.83% | 5.80% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.61B | 0.00% | 0.00% | -101.30% | -277.86% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.47B | -5.51% | 7.00% | -0.29% | -8.82% |
| Chemed Corporation (CHE)vs › | $6.63B | 10.60% | 11.45% | 11.66% | 12.42% |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 22.69% | 19.73% | -2.42% | -44.65% |
| Oscar Health, Inc. (OSCR)vs › | $8.02B | 3.60% | -1.75% | -5.71% | -20.27% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | -54.75% | -325.19% | -290.00% | -135445.82% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | -945.92% | -825.68% | -750.64% | -1236.10% |
Operating Margin
-16191.4%
Net Profit Margin
-3368.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -895.33% |
| 2026-03-31 | -8431.48% |
| 2025-12-31 | -15117.25% |
| 2025-09-30 | -11973.12% |
| 2025-06-30 | -23379.93% |
| 2025-03-31 | -15722.08% |
| 2024-12-31 | -106.60% |
| 2024-09-30 | -14276.08% |
| 2024-06-30 | -24450.29% |
| 2024-03-31 | -23133.13% |
| 2023-12-31 | 44.67% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | -111.06% |
| 2023-03-31 | -53.06% |
| 2022-12-31 | -1842916.67% |
| 2022-09-30 | -185690.43% |
| 2022-06-30 | -117616.46% |
| 2022-03-31 | -100683.71% |
| 2021-12-31 | -1095.03% |
| 2021-09-30 | -38648.33% |
| 2021-06-30 | 84.34% |
| 2021-03-31 | -56021.29% |
| 2020-12-31 | -28929.46% |
| 2020-09-30 | -62458.78% |
| 2020-06-30 | -181036.36% |
| 2020-03-31 | -44414.65% |
| 2019-12-31 | 39.66% |
| 2019-09-30 | 65.32% |
| 2019-06-30 | -16886.48% |
| 2019-03-31 | -14758.54% |
| 2018-12-31 | -41382.61% |
| 2018-09-30 | -9007.28% |
| 2018-06-30 | -3527.57% |
| 2018-03-31 | -2083.95% |
| 2017-12-31 | 0.44% |
| 2017-09-30 | -1035.06% |
| 2017-06-30 | -622.98% |
| 2017-03-31 | -794.49% |
| 2016-12-31 | 729.44% |
| 2016-09-30 | -948.61% |
| 2016-06-30 | -2158.99% |
| 2016-03-31 | -1773.53% |
| 2015-12-31 | -4974.09% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
